KRAS and neuroblastoma: Of note, SGSS05-NS3 is more selective for NB cells over non-tumor control cells, with a better safety profile and lower toxicity to normal cells, representing a significant advancement in the field of covalent SETD8 inhibitors, as the “non-covalent” affinity of SETD8 inhibitors like UNC0379 is in general low.